Bridging science, execution and capital in biotech
Technical expertise for advanced therapy development, from analytical strategy to critical development decisions.
Independent support when scientific complexity becomes a development, execution or investment decision.
PART OF THE UK LIFE SCIENCES ECOSYSTEM
THE DEVELOPMENT GAP
Strong science does not guarantee successful development.
As advanced therapy programmes progress, product understanding evolves, analytical gaps emerge, processes change and new development questions arise.
The challenge is often not generating more data. It is understanding which evidence matters, what it tells you, and whether it is sufficient for the decision in front of you.
Analytical fragility
Assays that don’t translate into reliable decisions.
Comparability risk
Changes that create regulatory and clinical uncertainty.
Manufacturing constraints
Processes that don’t scale or sustain.
AI is not execution
Models inform. Execution delivers and the gap between pilot and scale is wider than most teams expect.
WHO WE WORK WITH
Supporting organisations navigating complex development and adoption decisions.
Founders & Emerging Biotechs
Early-stage and emerging companies developing advanced therapies and navigating technical, analytical and development decisions.
Technology & Platform Developers
Teams innovating platforms that support cell or gene therapy development and need independent technical perspective.
CDMOs, Investors & Ecosystem Partners
Investors, partners and ecosystem organisations seeking independent technical perspective on advanced-therapy programmes, platforms or development readiness.
WHERE WE ADD VALUE
What we do
Cellvanta provides independent technical expertise across analytical development, product understanding and CMC strategy for advanced-therapy programmes.
Our expertise is flexible and not limited to the areas listed. If you have a technical question, development challenge or area in advanced therapies where you need additional expertise, get in touch to discuss how Cellvanta could help.
Product Understanding
Cell Therapy Assay Development
Potency & Functional Characterisation
CMC Strategy, Analytical Lifecycle & Comparability
